PTGS2 and arthritic joint disease: Normal NSAIDS are of critical safety concerns due to simultaneously inhibition of COX-1 and COX-2 enzymes in arthritis, while CURs can reduce the synthesis of COX-2 tendentiously [16], which may result in better safety profiles.